Rex Bionics PLC Directors Interests (9706K)

TIDMRXB

RNS Number : 9706K

Rex Bionics PLC

27 September 2016

Rex Bionics plc

("Rex Bionics" or the "Company")

Directors Interests

27 September 2016 Rex Bionics plc (AIM: RXB), the pioneer of the REX Robot technology that enhances the mobility of wheelchair users, announces that pursuant to the existing Deferred Bonus Share Plan (under which employees are issued options to subscribe for cash at par for Ordinary Shares in respect of the bonus to which they were otherwise entitled) the Company has made awards, for the financial year ended 31 March 2016, in respect of an aggregate of 791,279 Ordinary Shares of 10p each in the Company ("Ordinary Shares") (representing 3.1% of the current issued Ordinary Shares) to certain employees in the Company including the Chief Executive Officer, the Chief Financial Officer and the Chief Technology Officer.

The Awards to those Directors are as follows:

 
 Name                 Deferred Bonus Award 
                       Shares 
 Crispin Simon 
  Chief Executive 
  Officer            140,000 
 Peter Worrall 
  Chief Financial 
  Officer             93,333 
 Richard Little 
  Chief Technology 
  Officer             134,070 
 

For further information please contact:

Rex Bionics Plc

Peter Worrall, Chief Financial Officer

[phone]

Stifel Securities Limited (NOMAD and Broker)

Jonathan Senior, Stewart Wallace, Ben Maddison

[phone]

Consilium Strategic Communications

Lindsey Neville

[e-mail]

[phone]

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1.     Details of the person discharging managerial 
         responsibilities/person closely associated 
-----  ---------------------------------------------------------- 
 (a)    Name: CRISPIN SIMON 
-----  ---------------------------------------------------------- 
 
   2.     Reason for the notification 
-----  ---------------------------------------------------------- 
 (a)    Position/status: CHIEF EXECUTIVE 
-----  ---------------------------------------------------------- 
 (b)    Initial notification/Amendment: INITIAL 
-----  ---------------------------------------------------------- 
 
   3.     Details of the issuer, emission allowance market 
          participant, auction platform, auctioneer or 
          auction monitor 
-----  ---------------------------------------------------------- 
 (a)    Name: REX BIONICS plc 
-----  ---------------------------------------------------------- 
 (b)    LEI: NA 
-----  ---------------------------------------------------------- 
 
   4.     Details of the transaction(s): section to be 
          repeated for (i) each type of instrument; (ii) 
          each type of transaction; (iii) each date; 
          and (iv) each place where transactions have 
          been conducted 
-----  ---------------------------------------------------------- 
 (a)    Description of the Financial instrument, type 
         of instrument: Rex Bionics Option over Ordinary 
         Shares of 10p each 
         Identification code: ISIN: GB00BLRLQM66 
-----  ---------------------------------------------------------- 
 (b)    Nature of the transaction: Issue of awards 
         under Deferred Bonus Share Plan 
-----  ---------------------------------------------------------- 
 (c)    Price(s) and volume(s) 
         Price(s): 10p per Ordinary Share 
         Volume(s): 140,000 
-----  ---------------------------------------------------------- 
 (d)    Aggregated information 
          *    Aggregated volume: 140,000 Ordinary Shares awarded 
 
 
          *    Price: Exercise price: 10p per Ordinary Share 
-----  ---------------------------------------------------------- 
 (e)    Date of the transaction: 27 September 2016 
-----  ---------------------------------------------------------- 
 (f)    Place of the transaction: London Stock Exchange 
         - AIM 
-----  ---------------------------------------------------------- 
 
 
 1.     Details of the person discharging managerial 
         responsibilities/person closely associated 
-----  --------------------------------------------------------- 
 (a)    Name: PETER WORRALL 
-----  --------------------------------------------------------- 
 
   2.     Reason for the notification 
-----  --------------------------------------------------------- 
 (a)    Position/status: CHIEF FINANCIAL OFFICER 
-----  --------------------------------------------------------- 
 (b)    Initial notification/Amendment: INITIAL 
-----  --------------------------------------------------------- 
 
   3.     Details of the issuer, emission allowance market 
          participant, auction platform, auctioneer or 
          auction monitor 
-----  --------------------------------------------------------- 
 (a)    Name: REX BIONICS plc 
-----  --------------------------------------------------------- 
 (b)    LEI: NA 
-----  --------------------------------------------------------- 
 
   4.     Details of the transaction(s): section to be 
          repeated for (i) each type of instrument; (ii) 
          each type of transaction; (iii) each date; 
          and (iv) each place where transactions have 
          been conducted 
-----  --------------------------------------------------------- 
 (a)    Description of the Financial instrument, type 
         of instrument: Rex Bionics Option over Ordinary 
         Shares of 10p each 
         Identification code: ISIN: GB00BLRLQM66 
-----  --------------------------------------------------------- 
 (b)    Nature of the transaction: Issue of awards 
         under Deferred Bonus Share Plan 
-----  --------------------------------------------------------- 
 (c)    Price(s) and volume(s) 
         Price(s): 10p per Ordinary Share 
         Volume(s): 93,333 
-----  --------------------------------------------------------- 
 (d)    Aggregated information 
          *    Aggregated volume: 93,333 Ordinary Shares awarded 
 
 
          *    Price: Exercise price: 10p per Ordinary Share 
-----  --------------------------------------------------------- 
 (e)    Date of the transaction: 27 September 2016 
-----  --------------------------------------------------------- 
 (f)    Place of the transaction: London Stock Exchange 
         - AIM 
-----  --------------------------------------------------------- 
 
 
 1.     Details of the person discharging managerial 
         responsibilities/person closely associated 
-----  ---------------------------------------------------------- 
 (a)    Name: RICHARD LITTLE 
-----  ---------------------------------------------------------- 
 
   2.     Reason for the notification 
-----  ---------------------------------------------------------- 
 (a)    Position/status: CHIEF TECHNOLOGY OFFICER 
-----  ---------------------------------------------------------- 
 (b)    Initial notification/Amendment: INITIAL 
-----  ---------------------------------------------------------- 
 
   3.     Details of the issuer, emission allowance market 
          participant, auction platform, auctioneer or 
          auction monitor 
-----  ---------------------------------------------------------- 
 (a)    Name: REX BIONICS plc 
-----  ---------------------------------------------------------- 
 (b)    LEI: NA 
-----  ---------------------------------------------------------- 
 
   4.     Details of the transaction(s): section to be 
          repeated for (i) each type of instrument; (ii) 
          each type of transaction; (iii) each date; 
          and (iv) each place where transactions have 
          been conducted 
-----  ---------------------------------------------------------- 
 (a)    Description of the Financial instrument, type 
         of instrument: Rex Bionics Option over Ordinary 
         Shares of 10p each 
         Identification code: ISIN: GB00BLRLQM66 
-----  ---------------------------------------------------------- 
 (b)    Nature of the transaction: Issue of awards 
         under Deferred Bonus Share Plan 
-----  ---------------------------------------------------------- 
 (c)    Price(s) and volume(s) 
         Price(s): 10p per Ordinary Share 
         Volume(s): 134,070 
-----  ---------------------------------------------------------- 
 (d)    Aggregated information 
          *    Aggregated volume: 134,070 Ordinary Shares awarded 
 
 
          *    Price: Exercise price: 10p per Ordinary Share 
-----  ---------------------------------------------------------- 
 (e)    Date of the transaction: 27 September 2016 
-----  ---------------------------------------------------------- 
 (f)    Place of the transaction: London Stock Exchange 
         - AIM 
-----  ---------------------------------------------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHLLFELATIDFIR

(END) Dow Jones Newswires

September 27, 2016 08:00 ET (12:00 GMT)